Halozyme Therapeutics, Inc. dividends

Sorry, we have no dividends for Halozyme Therapeutics, Inc. (HALO) at the moment. :(

HALO

Price: $37.81

52 week price:
29.85
45.00

Earnings Per Share: 2.10 USD

P/E Ratio: 18.88

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 402302

Ebitda: 127.5 million

Market Capitalization: 5.1 billion

Links: